Search research articles
Contact Us
Filters
Showing results (231-240 of 288) with videos related to
Page
of 29
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
August 12, 2016
Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal Carcinoma
Nancy Lee, Heiko Schoder, Brad Beattie, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 24, 2011
Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases
Amita Shukla-Dave, Nancy Y Lee, Jacobus F A Jansen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 6, 2014
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)
M G Fury, E J Sherman, S S Rao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2003
The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue
Cherry L Estilo, Pornchai O-Charoenrat, Ivan Ngai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2012
A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancer
Matthew G Fury, Eric Sherman, Donna Lisa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2017
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
Joshua Bauml, Tanguy Y Seiwert, David G Pfister, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
August 4, 2010
[American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer]
Christopher G Azzoli, Sherman Baker, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2009
American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer
Christopher G Azzoli, Sherman Baker, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2001
Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology
A Recht, S B Edge, L J Solin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 9, 2011
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer
Christopher G Azzoli, Sarah Temin, Timothy Aliff, et al.
Page
of 29
Search research articles
Search
Showing results (231-240 of 288) with videos related to
Sort By:
Page
of 29
International Journal of Radiation Oncology, Biology, Physics
|
August 12, 2016
Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal Carcinoma
Nancy Lee, Heiko Schoder, Brad Beattie, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 24, 2011
Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases
Amita Shukla-Dave, Nancy Y Lee, Jacobus F A Jansen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 6, 2014
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)
M G Fury, E J Sherman, S S Rao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2003
The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue
Cherry L Estilo, Pornchai O-Charoenrat, Ivan Ngai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2012
A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancer
Matthew G Fury, Eric Sherman, Donna Lisa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2017
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
Joshua Bauml, Tanguy Y Seiwert, David G Pfister, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
August 4, 2010
[American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer]
Christopher G Azzoli, Sherman Baker, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2009
American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer
Christopher G Azzoli, Sherman Baker, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2001
Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology
A Recht, S B Edge, L J Solin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 9, 2011
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer
Christopher G Azzoli, Sarah Temin, Timothy Aliff, et al.
Page
of 29